Andrés Pichón-Rivière

Author

Instituto de Efectividad Clínica y Sanitaria ORCID

Also Known As

A Pichon-Riviere, A Pichón-Riviere, A Rivière, A. Pichon Riviere, A. Pichon riviere, A. Pichon-Riviere, A. Pichón Riviere, A. Pichón-Riviere, A. Riviere, A. Rivière

226

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Instituto de Efectividad Clínica y Sanitaria Universidad de Buenos Aires University of York Consejo Nacional de Investigaciones Científicas y Técnicas Hospital Italiano de Buenos Aires

About

Andrés Pichón-Rivière is an author at Instituto de Efectividad Clínica y Sanitaria specializing in public health, health economics, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Public Health	7	7	277
2	Medicine	4	4	112
3	Business	1	1	30
4	Health Sciences	1	1	99
5	Economics	1	1	30

Andrés Pichón-Rivière

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
A Cross-Sectional Study of the Microeconomic Impact of Cardiovascular Disease Hospitalization in Four Low- and Middle-Income Countries Mark D. Huffman, Andrés Pichón-Rivière, Dong Zhao, PLoS ONE	2011	260
Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures Andrés Pichón-Rivière, Michael Drummond, Alfredo Palacios, The Lancet Global Health	2023	217
Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina Adolfo Rubinstein, Lisandro D. Colantonio, Ariel Bardach, BMC Public Health	2010	104
Priority-Setting Institutions in Health: Recommendations from a Center for Global Development Working Group Amanda Glassman, Kalipso Chalkidou, Úrsula Giedión, Global Heart Priority-setting InstitutionsComparative Health SystemsGlobal SupportHealth PoliticsSocial Determinants Of Health	2012	99
The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study Andrés Pichón-Rivière, Andrea Alcaraz, Alfredo Palacios, The Lancet Global Health	2020	76
Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study Fernando Rubinstein, Paula Micone, Ana María Bonotti, BMJ	2013	65
Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions Federico Augustovski, Lisandro D. Colantonio, Julieta Galante, International Journal of Health Policy and Management	2017	52
Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries Lisandro D. Colantonio, Jorge A. Gómez, Nadia Demarteau, Vaccine VaccinationPreventive MedicineCost-effectiveness AnalysisCervical HealthHealth Economics	2009	47
Development and Validation of a Microsimulation Economic Model to Evaluate the Disease Burden Associated with Smoking and the Cost-Effectiveness of Tobacco Control Interventions in Latin America Andrés Pichón-Rivière, Federico Augustovski, Ariel Bardach, Value in Health Tobacco CessationTobacco ControlPreventive MedicineHealth PolicyHealth Economics	2011	42
A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries Sebastián García Martí, Lisandro D. Colantonio, Ariel Bardach, Cost Effectiveness and Resource Allocation	2013	42

Page 1